Perfusion delivers detergents, enzymes, and rinsing solutions through the pancreatic vascular network, helping expose internal regions more uniformly than surface treatment alone. Because the vascular structure is also part of the target scaffold, processing must clear cellular material while limiting disruption to these channels. Preserving that network can improve the resulting matrix’s usefulness for later tissue engineering studies.
Detergents help lyse pancreatic cells, enzymes contribute to breaking down cellular components, and repeated rinsing clears the released material. DNA and other cellular residues must be removed without causing excessive injury to the extracellular matrix. The combined sequence therefore balances effective cell removal with preservation of the biochemical and structural features needed for scaffold-based research.
The extracellular matrix retains biochemical cues and spatial organization that are lost when tissue is reduced to isolated components. Its three-dimensional architecture can provide a more tissue-relevant microenvironment for studying pancreatic biology. Maintaining these features also gives pancreatic or stem-cell-derived cells a structural context during investigations of engineered tissues and regenerative strategies.
Perfusion introduces processing solutions through the tissue’s vascular pathways, whereas immersion exposes the tissue by surrounding it with the solution. Both approaches can be paired with detergents, enzymes, and rinsing, but they differ in how solutions reach internal regions. The choice is relevant when researchers aim to balance thorough cellular clearance with preservation of vascular and matrix structures.
A typical workflow applies detergents and enzymes to disrupt and remove cells, followed by rinsing steps that clear DNA and other cellular components. Researchers may deliver these solutions by perfusion or immersion, then evaluate whether the extracellular matrix, three-dimensional structure, and vascular features remain sufficiently preserved. This sequence prepares the acellular scaffold for subsequent study or recellularization.
These scaffolds provide platforms for examining pancreatic microenvironments, modeling disease-related questions, and developing engineered tissues for diabetes research. They can also be recellularized with pancreatic cells or stem-cell-derived cells to investigate regenerative medicine strategies. In the longer term, this work may inform approaches related to islet transplantation, although the scaffold primarily serves as an experimental platform.